Keyphrases
Sexual Dysfunction
64%
Erectile Dysfunction
50%
Sexual Behavior
34%
Gender-affirming Surgery
32%
Prospective Controlled Study
32%
Vulvoplasty
32%
Inhibin
32%
Serum Human Chorionic Gonadotropin
32%
Sex Life
32%
Gender Incongruence
32%
Negative Effects
32%
Puberty Timing
32%
Expectant Management
32%
Gender-affirming Hormone Therapy
32%
Transfeminine
32%
Breast Cancer Survivors
32%
Reproductive Patterns
32%
Informed Patient
32%
Pharmacological Treatment
32%
Nephrectomy
32%
Adjuvant Endocrine Treatment
32%
Female Sexual Health
32%
Patient Survey
32%
Ejaculatory Dysfunction
32%
Retrograde Ejaculation
32%
Bioelectrical Impedance Analysis
32%
Transgender
32%
Absorptiometry
25%
Kidney Cancer
21%
Sexual Relationships
21%
After Surgery
21%
Vaginal Dryness
21%
Denmark
21%
University Hospital
21%
Sexually Active
21%
Body Composition
19%
Sex at Birth
18%
Plasma Estradiol
13%
Fat Mass
12%
Bottom Surgery
12%
Material Comparison
10%
Treatment Course
10%
Female Participants
10%
Method Comparison
10%
Psychosocial Factors
10%
Medication Use
10%
Treatment Termination
10%
Treatment Outcome
10%
Urology Department
10%
Before Surgery
10%
Medicine and Dentistry
Hormone Therapy
100%
Breast Cancer
96%
Cross Sectional Study
42%
Childbirth
35%
Diabetes Mellitus
32%
Lichen Sclerosus
32%
Retrograde Ejaculation
32%
Chorionic Gonadotropin
32%
Adjuvant Endocrine Therapy
32%
Nephrectomy
32%
Outpatient
32%
Ejaculation Disorder
32%
Cohort Analysis
32%
Human Immunodeficiency Virus
32%
Progesterone
32%
First Trimester Pregnancy
32%
Adolescent
28%
Side Effect
24%
Vaginal Dryness
21%
Kidney Cancer
21%
Prevalence
18%
Erectile Dysfunction
17%
Cancer Therapy
17%
Quality of Life
15%
Symptom
13%
Retrospective Study
10%
Urology
10%
Patient Experience
10%
Pregnancy
9%
Cancer Diagnosis
9%
Physician
8%
Vagina Reconstruction
8%
Multivariate Analysis
7%
Dyspareunia
7%
Sensitivity and Specificity
6%
Ectopic Pregnancy
6%
Transgender
5%
Nursing and Health Professions
Hormonal Therapy
89%
Breast Cancer
64%
Cross-Sectional Study
35%
Transgender
35%
Hospital
34%
Lichen Sclerosus Et Atrophicus
32%
Cohort Analysis
32%
Adolescent
32%
Absorptiometry
32%
Body Composition
24%
Vaginal Dryness
21%
Confidence Interval
18%
Muscle Mass
16%
Fat Mass
16%
Prevalence
11%
Side Effect
11%
Cancer Therapy
10%
Symptom
6%
Physician
6%
Female Physician
5%
